Patricia Martin
CEO
Indianapolis, Indiana
Overview
Work Experience
Board Member
2024 - Current
Board Member
2023
NASDAQ: LPTX
Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.
Raised $266,500,000.00 from Laurion Capital Management, 683 CAPITAL, Samsara BioCapital, Rock Springs Capital, Gilead Sciences, BeiGene, Lincoln Park Capital Fund and Eli Lilly & Company Foundation.
Board Member
2021
NASDAQ: ANTX
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Raised $162,000,000.00 from Bill & Melinda Gates Foundation and Bill & Melinda Gates Foundation.
Board Member
2021
Finance/Audit Committee Chair
Regenstrief Institute is a medical R&D organization in electronic medical records and health care data integration.
Board Member
2015 - 2023
Board Member, Compensation Committee - Chair, Risk Committee - Member To make a lasting difference in our members’ lives by improving their health and well-being.
President and CEO | Advancing Indiana's Life Sciences Sector via Research and Collaboration
2019 - 2023
BioCrossroads is a venture capital firm specializing in life sciences companies based in Indiana.
Raised $1,480,000.00 from Richard M. Fairbanks Foundation.
Board Member
2019 - 2023
Board Member
2019 - 2023
Managing Partner | Championing Indiana's Life Sciences Ecosystem through Seed Funding
2019 - 2023
Interim CEO
2021 - 2023
Led wind-down of operations and merger negotiations and integration into Leap Therapeuticx, Incl (LPTX)
Board Member
2020 - 2023